13.01
2.40%
-0.32
After Hours:
13.0499
0.0399
+0.31%
Teladoc Health Inc stock is currently priced at $13.01, with a 24-hour trading volume of 7.61M.
It has seen a -2.40% decreased in the last 24 hours and a -13.55% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $13.37 pivot point. If it approaches the $12.82 support level, significant changes may occur.
Previous Close:
$13.33
Open:
$12.68
24h Volume:
7.61M
Market Cap:
$2.20B
Revenue:
$2.60B
Net Income/Loss:
$-220.37M
P/E Ratio:
-0.5276
EPS:
-24.66
Net Cash Flow:
$193.67M
1W Performance:
+0.23%
1M Performance:
-13.55%
6M Performance:
-19.14%
1Y Performance:
-49.51%
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
203-635-2002
Address
2 Manhattanville Road, Suite 203, Purchase, NY
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
Jan-03-24 | Initiated | Barclays | Overweight |
Apr-12-23 | Initiated | Stephens | Equal-Weight |
Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
Aug-12-22 | Initiated | DA Davidson | Buy |
Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
Jul-28-22 | Downgrade | Needham | Buy → Hold |
Jul-06-22 | Reiterated | BofA Securities | Neutral |
May-05-22 | Downgrade | Argus | Buy → Hold |
Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-01-22 | Resumed | Credit Suisse | Outperform |
Mar-03-22 | Upgrade | Argus | Hold → Buy |
Feb-23-22 | Reiterated | BofA Securities | Neutral |
Feb-23-22 | Reiterated | Craig Hallum | Hold |
Feb-23-22 | Reiterated | Evercore ISI | In-line |
Feb-23-22 | Reiterated | Goldman | Buy |
Feb-23-22 | Reiterated | JP Morgan | Overweight |
Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
Feb-23-22 | Reiterated | Needham | Buy |
Feb-23-22 | Reiterated | Oppenheimer | Outperform |
Feb-23-22 | Reiterated | Stifel | Hold |
Feb-11-22 | Initiated | Goldman | Buy |
Feb-08-22 | Reiterated | Piper Sandler | Overweight |
Dec-02-21 | Resumed | Jefferies | Hold |
Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
Oct-28-21 | Reiterated | Barclays | Equal Weight |
Oct-28-21 | Reiterated | BofA Securities | Neutral |
Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
Oct-28-21 | Reiterated | Citigroup | Buy |
Oct-28-21 | Reiterated | Craig Hallum | Hold |
Oct-28-21 | Reiterated | Needham | Buy |
Oct-28-21 | Reiterated | Oppenheimer | Outperform |
Oct-28-21 | Reiterated | Piper Sandler | Overweight |
Oct-28-21 | Reiterated | UBS | Neutral |
Oct-19-21 | Initiated | Wells Fargo | Overweight |
Aug-02-21 | Downgrade | Argus | Buy → Hold |
Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
May-28-21 | Initiated | Robert W. Baird | Neutral |
Apr-15-21 | Initiated | Needham | Buy |
Jan-07-21 | Initiated | BTIG Research | Buy |
Dec-22-20 | Initiated | Evercore ISI | In-line |
Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Dec-04-20 | Initiated | Goldman | Neutral |
Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-22-20 | Initiated | DA Davidson | Buy |
Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Jul-14-20 | Initiated | Citigroup | Buy |
Jul-13-20 | Initiated | Argus | Buy |
Jul-07-20 | Initiated | Stephens | Overweight |
Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-13-20 | Initiated | SVB Leerink | Outperform |
Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-10-20 | Initiated | UBS | Neutral |
Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Why Teladoc Health Stock Dived on Friday
The Motley Fool
13 Analysts Assess Teladoc Health: What You Need To Know
Benzinga
2 Bargain Growth Stocks to Buy Right Now
The Motley Fool
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
Benzinga
Teladoc Health (TDOC) Q1 2024 Earnings Call Transcript
The Motley Fool
Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Teladoc Health Inc Stock (TDOC) Financials Data
Teladoc Health Inc (TDOC) Revenue 2024
TDOC reported a revenue (TTM) of $2.60 billion for the quarter ending December 31, 2023, a +8.13% rise year-over-year.
Teladoc Health Inc (TDOC) Net Income 2024
TDOC net income (TTM) was -$220.37 million for the quarter ending December 31, 2023, a +98.39% increase year-over-year.
Teladoc Health Inc (TDOC) Cash Flow 2024
TDOC recorded a free cash flow (TTM) of $193.67 million for the quarter ending December 31, 2023, a +1,072% increase year-over-year.
Teladoc Health Inc (TDOC) Earnings per Share 2024
TDOC earnings per share (TTM) was -$1.34 for the quarter ending December 31, 2023, a +98.42% growth year-over-year.
About Teladoc Health Inc
Teladoc Health, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Cap:
|
Volume (24h):